{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:53:36Z","timestamp":1761897216733,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.4158\/ep-2019-0468","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T13:14:44Z","timestamp":1583932484000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Outcomes of Radioiodine Therapy for Juvenile Graves Disease with Emphasis on Subsequently Detected Thyroid Nodules: A Single Institution Experience from Japan"],"prefix":"10.1016","volume":"26","author":[{"given":"Tetsuya","family":"Mizokami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0468_bb0010","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-1944","article-title":"French Childhood Graves' Disease Study Group. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: national long-term cohort study","volume":"97","author":"L\u00e9ger","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jpem-2015-0333","article-title":"Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease","volume":"29","author":"Cohen","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0020","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamainternmed.2019.0981","article-title":"Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism","volume":"179","author":"Kitahara","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.4158\/EP-2019-0468_bb0025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.4158\/EP-2019-0468_bb0030","first-page":"3767","article-title":"Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment","volume":"83","author":"Rivkees","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jc.2006-1239","article-title":"An optimal treatment for pediatric Graves' disease is radioiodine","volume":"92","author":"Rivkees","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00431-009-0992-2","article-title":"Radioiodine treatment for pediatric hyperthyroid Grave's disease","volume":"168","author":"Chao","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.4158\/EP-2019-0468_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5005\/jp-journals-10002-1026","article-title":"Radioiodine for treatment of Graves' disease in pediatric population: an ideal treatment","volume":"2","author":"Gambhir","year":"2010","journal-title":"World J Endocr Surg"},{"key":"10.4158\/EP-2019-0468_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1515\/jpem-2014-0176","article-title":"Should radio-iodine be the first-line treatment for paediatric Graves' disease?","volume":"28","author":"West","year":"2015","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.4158\/EP-2019-0468_bb0055","first-page":"15","article-title":"Radioactive iodine therapy for patients with Graves' disease aged 18 or younger [in Japanese; abstract in English]","volume":"112","author":"Ogawa","year":"2008","journal-title":"J Jpn Pediatr Soc"},{"key":"10.4158\/EP-2019-0468_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1687-9856-2011-14","article-title":"Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease","volume":"2011","author":"Nakatake","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0468_bb0065","first-page":"75","article-title":"Radioiodine treatment in patients with Graves' disease at outpatient clinic: Special reference to safety and short-term outcome [in Japanese; abstract in English]","volume":"43","author":"Tajiri","year":"2006","journal-title":"Kaku Igaku"},{"key":"10.4158\/EP-2019-0468_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1507\/endocrj.EJ11-0279","article-title":"Prediction of late (24-hour) radioactive iodine uptake using early (3-hour) uptake values in Japanese patients with Graves' disease","volume":"59","author":"Osaki","year":"2012","journal-title":"Endocr J"},{"key":"10.4158\/EP-2019-0468_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.4158\/EP-2019-0468_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1297\/cpe.26.29","article-title":"Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016","volume":"26","author":"Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Taskforce for the revision of the guidelines for the treatment of childhood-onset Graves' disease)","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0468_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.arcmed.2006.09.007","article-title":"Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage","volume":"38","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2007","journal-title":"Arch Med Res"},{"key":"10.4158\/EP-2019-0468_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mpd.2002.125494","article-title":"Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children","volume":"141","author":"Nebesio","year":"2002","journal-title":"J Pediatr"},{"key":"10.4158\/EP-2019-0468_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1530\/EC-12-0049","article-title":"Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease","volume":"2","author":"Cury","year":"2012","journal-title":"Endocr Connect"},{"key":"10.4158\/EP-2019-0468_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1687-9856-2014-10","article-title":"Pediatric Graves' disease: management in the post-propylthiouracil era","volume":"2014","author":"Rivkees","year":"2014","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0468_bb0105","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.bjc.6690425","article-title":"Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease","volume":"80","author":"Shafford","year":"1999","journal-title":"Br J Cancer"},{"key":"10.4158\/EP-2019-0468_bb0110","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-38-6-976","article-title":"Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study","volume":"38","author":"Dobyns","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0115","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1210\/jc.2015-3100","article-title":"The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk","volume":"100","author":"Kwong","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/js.2018-00287","article-title":"Influence of Hashimoto thyroiditis on the development of thyroid nodules and cancer in children and adolescents","volume":"3","author":"Radetti","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.4158\/EP-2019-0468_bb0125","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","article-title":"A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients","volume":"89","author":"Read","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0468_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/jpem-2017-0394","article-title":"Management of thyrotoxicosis in children and adolescents: 35 years' experience in 304 patients","volume":"31","author":"Azizi","year":"2018","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:20Z","timestamp":1761516500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20360110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1530891X20360110"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0468","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes of Radioiodine Therapy for Juvenile Graves Disease with Emphasis on Subsequently Detected Thyroid Nodules: A Single Institution Experience from Japan","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}